Treatment of alzheimer's disease employing inhibitors of cathepsin D
US6251928A · kind A · utility
4Cited by
14References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 1994 |
| Grant date | Jun 26, 2001 |
| Priority date | — |
| Expiry date | Mar 16, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention provides novel benzylidene rhodanines which are useful as agents in treating or preventing conditions associated with .beta.-amyloid peptide. This invention further provides methods of treating or preventing Alzheimer's Disease which comprises administering to a mammal in need thereof an effective amount of one or more of the benzylidene rhodanines of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.